Norges Bank’s Cogent Biosciences COGT Stock Holding History

Norges Bank’s Portfolio COGT Stock Details COGT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-25,000	Closed	-$1.11M	–	2135
2018 Q1	$1.11M	Buy	+25,000	New	+$1.11M	﹤0.01%	2054

Other funds holding COGT

AVAI

Atlas Venture Associates IX Boston, Massachusetts $11.8M AUM 58.35% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

NLVP

New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

SAM

Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

NHAS

Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Norges Bank's COGT Position: Q2 2018 in Review

Norges Bank sold out of Cogent Biosciences (COGT) in Q2 2018, closing a stake of 25,000 shares — an estimated $1.11M sold.

Norges Bank first reported a position in COGT in Q1 2018 and held it in 1 quarter. The position peaked at $1.11M in Q1 2018. 44 funds tracked by Wall St. Rank hold COGT as of Q2 2018.

Norges Bank reported no remaining Cogent Biosciences position as of Q2 2018 after selling out during the quarter.
Norges Bank sold 25,000 Cogent Biosciences shares in Q2 2018, an estimated $1.11M.
Norges Bank first reported a position in Cogent Biosciences in Q1 2018 and held it in 1 quarter.
Norges Bank's Cogent Biosciences position peaked at $1.11M in Q1 2018.
44 funds tracked by Wall St. Rank held Cogent Biosciences as of Q2 2018.

Based on Norges Bank's 13F filing for Q2 2018, filed 23 Jul 2018.